NOVAREX Co.Ltd (194700) - Total Liabilities

Latest as of December 2025: ₩104.91 Billion KRW ≈ $71.10 Million USD

Based on the latest financial reports, NOVAREX Co.Ltd (194700) has total liabilities worth ₩104.91 Billion KRW (≈ $71.10 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 194700 operating cash flow to assess how effectively this company generates cash.

NOVAREX Co.Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how NOVAREX Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 194700 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

NOVAREX Co.Ltd Competitors by Total Liabilities

The table below lists competitors of NOVAREX Co.Ltd ranked by their total liabilities.

Company Country Total Liabilities
Parrot
PA:PARRO
France €36.60 Million
Vina San Pedro
SN:VSPT
Chile CL$159.71 Billion
Dynamix Corporation
NASDAQ:ETHM
USA $27.35 Million
CHC Healthcare Group
TW:4164
Taiwan NT$6.86 Billion
FineTek Co Ltd
TWO:4549
Taiwan NT$781.20 Million
Wei Chih Steel Industrial Co Ltd
TW:2028
Taiwan NT$3.74 Billion
TIDEWATER RENEWABLES LTD
F:7GZ
Germany €242.40 Million
Amrutanjan Health Care Limited
NSE:AMRUTANJAN
India Rs902.90 Million

Liability Composition Analysis (2015–2025)

This chart breaks down NOVAREX Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NOVAREX Co.Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.26 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.41 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.29 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NOVAREX Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NOVAREX Co.Ltd (2015–2025)

The table below shows the annual total liabilities of NOVAREX Co.Ltd from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 ₩104.91 Billion
≈ $71.10 Million
+51.29%
2024-12-31 ₩69.35 Billion
≈ $47.00 Million
+7.82%
2023-12-31 ₩64.32 Billion
≈ $43.59 Million
-27.91%
2022-12-31 ₩89.21 Billion
≈ $60.46 Million
-22.40%
2021-12-31 ₩114.96 Billion
≈ $77.91 Million
+15.09%
2020-12-31 ₩99.89 Billion
≈ $67.70 Million
+59.62%
2019-12-31 ₩62.58 Billion
≈ $42.41 Million
+128.43%
2018-12-31 ₩27.40 Billion
≈ $18.57 Million
+37.52%
2017-12-31 ₩19.92 Billion
≈ $13.50 Million
+27.79%
2016-12-31 ₩15.59 Billion
≈ $10.56 Million
-21.77%
2015-12-31 ₩19.93 Billion
≈ $13.51 Million
--

About NOVAREX Co.Ltd

KQ:194700 Korea Packaged Foods
Market Cap
$178.75 Million
₩263.76 Billion KRW
Market Cap Rank
#16964 Global
#743 in Korea
Share Price
₩14900.00
Change (1 day)
-1.97%
52-Week Range
₩11290.00 - ₩22000.00
All Time High
₩23604.80
About

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science C… Read more